Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Iroko gains control of SoluMatrix platform in iCeutica takeover

Executive Summary

Spec pharma Iroko Pharmaceuticals LLC has paid an undisclosed amount for fellow private drug reformulation specialist iCeutica Inc., which said the purchase price is a 10x-plus step-up to the post-money valuation of the company’s $1mm Series A financing in 2005.
Deal Industry
  • Biotechnology
    • Nanotechnology, Chips, etc.
  • Pharmaceuticals
    • Drug Delivery
      • Nasal
      • Pulmonary
Deal Status
  • Final
Deal Type
  • Acquisition
    • Payment Includes Cash
    • Full Acquisition
    • Acquisition of Private Biotech

Related Companies